DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» FOLFIRINOX
FOLFIRINOX
Pre-Operative Chemotherapy for Colorectal Cancer with Liver Metastases and Conversion Therapy
Paclitaxel Protein-Bound Monograph
Pancreatic Adenocarcinoma Treatment Regimens
The Efficacy and Safety of Modified FOLFIRINOX As First-Line
Preoperative Modified FOLFIRINOX Treatment Followed By
Chemo Cheat Sheet
Fluorouracil-Folinic Acid-Irinotecan-Oxaliplatin
Adjuvant Chemotherapy for Stage III Colon Cancer
An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma
FOLFIRINOX Versus Gemcitabine-Based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-Derived Cell Lines SEBASTIAN K.S
Population Pharmacokinetics of FOLFIRINOX: a Review of Studies and Parameters
Total Neoadjuvant Therapy with FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma a Phase 2 Clinical Trial
Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021
Total Neoadjuvant Therapy with FOLFIRINOX Followed By
Gemcitabine/Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: a European Multicenter Study
Comparative Efficacy of Modified FOLFIRINOX, Gemcitabine Plus
Efficacy and Safety of FOLFIRINOX As Salvage Treatment in Advanced
Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Vs
Top View
FOLFIRINOX: from the ACCORD Study to 2014 Highlights from the “2014 ASCO Gastrointestinal Cancers Symposium”
ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer Michael J
(Stage III- IV) Ductal Pancreatic Adenocarcinoma Using Metabolically
Systemic Treatment and Outcomes of Metastatic Pancreatic Cancer
US Food and Drug Administration Approves Paclitaxel
Modified FOLFIRINOX As a Second-Line Therapy Following
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
Surgery with Curative-Intent in Patients Treated with First-Line Chemotherapy
Physician Orders
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine Versus FOLFIRINOX
Phase II Study of FOLFIRINOX Chemotherapy for Treatment of Advanced Gastric, Gastro- Esophageal Junction, and Esophageal Tumors
Colorectal Cancer‐ What Is Best and When?
BC Cancer Protocol Summary for Palliative Combination Chemotherapy for Advanced Pancreatic Adenocarcinoma Using Irinotecan, Oxaliplatin, Fluorouracil and Leucovorin
Regimen Reference Order – GAST – Mod FOLFIRINOX
207793Orig1s000
FOLFIRINOX Disease Was FOLFIRINOX, Treatment Line Metastatic from of Beginning Age, for TABLE TABLE 1
Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients
FOLFIRINOX (Irinotecan, Oxaliplatin & Infusional Fluorouracil)